newsfilter
← Latest News
GlobeNewswire·

NexImmune Reports Third Quarter 2021 Financial Results and Provides Business Updates

Advancing two lead product candidates in Phase 1/2 clinical trials Additional clinical and preclinical data anticipated by year end 2021 and first half 2022 Announced collaboration with Yale University Department of Immunobiology to explore use of AI